## Core Concept
The question tests knowledge of pharmacodynamics and pharmacokinetics of inhaled bronchodilators, specifically their onset of action. Inhaled bronchodilators are crucial in managing obstructive airway diseases like asthma and COPD. They work by relaxing bronchial smooth muscles, thereby increasing airflow.

## Why the Correct Answer is Right
Salbutamol (also known as albuterol) is a short-acting β2-adrenergic receptor agonist (SABA). It acts quickly by stimulating β2 receptors in the lungs, leading to bronchodilation. Its fast onset of action, typically within 1-5 minutes, makes it ideal for relieving acute bronchospasm. Salbutamol's rapid action is due to its high lipophilicity, allowing quick absorption into the bloodstream and then into the lung tissue.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is also blank and cannot be assessed.
- **Option C:** Ipratropium is an anticholinergic bronchodilator. While effective, it has a slower onset of action compared to salbutamol, typically taking 15-30 minutes to exert its full effect. It works by blocking muscarinic acetylcholine receptors, preventing bronchoconstriction.
- **Option D:** This option is blank and cannot be evaluated.

## Clinical Pearl / High-Yield Fact
A key point to remember is that for immediate relief of bronchospasm, especially in acute asthma attacks, salbutamol (albuterol) is the drug of choice due to its rapid onset of action. Its effectiveness and quick action make it a cornerstone in emergency medicine and respiratory care.

## Correct Answer: C. Salbutamol.